Atypical mycobacterial infections

Unlabeled Uses Treatment of atypical mycobacterial infections... [Pg.184]

Uniabeled Uses Treatment of atypical mycobacterial infections, gonorrhea, malaria, rheumatoid arthritis prevention of Lyme disease prevention or treatment of traveler s diarrhea. [Pg.403]

Unlabeled Uses Treatment of atypical mycobacterial infections such as Mycobacterium avium complex (MAC)... [Pg.472]

Unlabeled Uses Prophylaxis of Haemophilus influenzae type b infection treatment of atypical mycobacterial infection and serious infections caused by Staphybcoccus spe-... [Pg.1087]

Ciprofloxacin and levofloxacin are no longer recommended for the treatment of gonococcal infection in the USA as resistance is now common. However, both drugs are effective in treating chlamydial urethritis or cervicitis. Ciprofloxacin, levofloxacin, or moxifloxacin is occasionally used for treatment of tuberculosis and atypical mycobacterial infections. These agents may be suitable for eradication of meningococci from carriers or for prophylaxis of infection in neutropenic patients. [Pg.1038]

Rifampin, usually 600 mg/d (10 mg/kg/d) orally, must be administered with isoniazid or other antituberculous drugs to patients with active tuberculosis to prevent emergence of drug-resistant mycobacteria. In some short-course therapies, 600 mg of rifampin are given twice weekly. Rifampin 600 mg daily or twice weekly for 6 months also is effective in combination with other agents in some atypical mycobacterial infections and in leprosy. Rifampin, 600 mg daily for 4 months as a single drug, is an alternative to isoniazid prophylaxis for patients with latent tuberculosis only, who are unable to take isoniazid or who have had exposure to a case of active tuberculosis caused by an isoniazid-resistant, rifampin-susceptible strain. [Pg.1046]

Rifabutin is effective in prevention and treatment of disseminated atypical mycobacterial infection in AIDS patients with CD4 counts below 50/pL. It is also effective for preventive therapy of tuberculosis, either alone in a 3-4 month regimen or with pyrazinamide in a 2-month regimen. [Pg.1050]

Ethambutol Inhibits mycobacterial arabinosyl transferases, which are involved in the polymerization reaction of arabinoglycan an essential component of the mycobacterial cell wall Bacteriostatic activity against susceptible mycobacteria Given as four-drug initial combination therapy for tuberculosis until drug sensitivities are known also used for atypical mycobacterial infections Oral t mixed clearance (half-life 4 h) dose must be reduced in renal failure Toxicity Retrobulbar neuritis... [Pg.1053]

Joos AA, Frank UG, Kaschka WP. Pharmacokinetic interaction of clozapine and rifampicin in a forensic patient with an atypical mycobacterial infection. J Clin Psychopharmacol 1998 18(l) 83-5. [Pg.290]

Mycobacterium avium Atypical mycobacterial infections, AIDS More convenient specimens definitive species identification F5... [Pg.186]

Clarithromycin is an H. pylori agent/macrolide, which inhibits microbial protein synthesis. Clarithromycin is indicated in the treatment of infections of the respiratory tract, skin and skin structure treatment of disseminated atypical mycobacterial infections caused by susceptible strains of specific microorganisms and prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infection. Clarithromycin in combination with omeprazole is indicated in the treatment of patients with an active duodenal ulcer associated with H. pylori infection. In children it is used in acute otitis media. Macrolides are erythromycin, clarithromycin, and azithromycin. [Pg.160]

Antibiotic prophylaxis, often with an oral fluoroquinolone, is used to prevent a variety of infections in patients undergoing organ transplantation or receiving cancer chemotherapy. Prophylaxis is recommended for primary and secondary prevention of opportunistic infections in AIDS patients whose CD4 counts are below certain thresholds (e.g., <200 cell/mm for the prevention of Pneumocystis pneumonia and <50 cells/mm for prevention of atypical mycobacterial infections). [Pg.712]

Hautmann G, Lotti T (1994) Atypical mycobacterial infections of the skin. Dermatol Clin 12 657-668... [Pg.1108]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...